Global Placental Stem Cell Therapy for Neurological Disorders Market Growth (Status and Outlook) 2026-2032
The global Placental Stem Cell Therapy for Neurological Disorders market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson's disease, Alzheimer's, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.
The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there's a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.
LPI (LP Information)' newest research report, the “Placental Stem Cell Therapy for Neurological Disorders Industry Forecast” looks at past sales and reviews total world Placental Stem Cell Therapy for Neurological Disorders sales in 2025, providing a comprehensive analysis by region and market sector of projected Placental Stem Cell Therapy for Neurological Disorders sales for 2026 through 2032. With Placental Stem Cell Therapy for Neurological Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Placental Stem Cell Therapy for Neurological Disorders industry.
This Insight Report provides a comprehensive analysis of the global Placental Stem Cell Therapy for Neurological Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Placental Stem Cell Therapy for Neurological Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Placental Stem Cell Therapy for Neurological Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Placental Stem Cell Therapy for Neurological Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Placental Stem Cell Therapy for Neurological Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Placental Stem Cell Therapy for Neurological Disorders market by product type, application, key players and key regions and countries.
Segmentation by Type:
Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson's disease, Alzheimer's, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.
The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there's a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.
LPI (LP Information)' newest research report, the “Placental Stem Cell Therapy for Neurological Disorders Industry Forecast” looks at past sales and reviews total world Placental Stem Cell Therapy for Neurological Disorders sales in 2025, providing a comprehensive analysis by region and market sector of projected Placental Stem Cell Therapy for Neurological Disorders sales for 2026 through 2032. With Placental Stem Cell Therapy for Neurological Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Placental Stem Cell Therapy for Neurological Disorders industry.
This Insight Report provides a comprehensive analysis of the global Placental Stem Cell Therapy for Neurological Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Placental Stem Cell Therapy for Neurological Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Placental Stem Cell Therapy for Neurological Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Placental Stem Cell Therapy for Neurological Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Placental Stem Cell Therapy for Neurological Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Placental Stem Cell Therapy for Neurological Disorders market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Allogeneic Placental Stem Cell Therapy
- Autologous Placental Stem Cell Therapy
- Hospitals and Specialist Clinics
- Clinical Research Institute
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mesoblast
- Pleurite Therapeutic
- Athersys
- Cordlife India
- Life Cell
- Cryo-Cell
- CBR Systems
- ReNeuron Group
- Cynata
- Celularity
- Americord Registry
- ReeLabs
- Mesoblast
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size (2021-2032)
2.1.2 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Placental Stem Cell Therapy for Neurological Disorders by Country/Region (2021, 2025 & 2032)
2.2 Placental Stem Cell Therapy for Neurological Disorders Segment by Type
2.2.1 Allogeneic Placental Stem Cell Therapy
2.2.2 Autologous Placental Stem Cell Therapy
2.2.3 Placental Stem Cell Therapy for Neurological Disorders Market Size by Type
2.2.3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
2.3 Placental Stem Cell Therapy for Neurological Disorders Segment by Application
2.3.1 Hospitals and Specialist Clinics
2.3.2 Clinical Research Institute
2.3.3 Placental Stem Cell Therapy for Neurological Disorders Market Size by Application
2.3.3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
3 PLACENTAL STEM CELL THERAPY FOR NEUROLOGICAL DISORDERS MARKET SIZE BY PLAYER
3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Player
3.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2021-2026)
3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player (2021-2026)
3.2 Global Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PLACENTAL STEM CELL THERAPY FOR NEUROLOGICAL DISORDERS BY REGION
4.1 Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026)
4.2 Global Placental Stem Cell Therapy for Neurological Disorders Annual Revenue by Country/Region (2021-2026)
4.3 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
4.4 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
4.5 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
4.6 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026)
5.2 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
5.3 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026)
6.2 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
6.3 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026)
7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders by Region (2021-2026)
8.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
8.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PLACENTAL STEM CELL THERAPY FOR NEUROLOGICAL DISORDERS MARKET FORECAST
10.1 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.1.2 Americas Placental Stem Cell Therapy for Neurological Disorders Forecast
10.1.3 APAC Placental Stem Cell Therapy for Neurological Disorders Forecast
10.1.4 Europe Placental Stem Cell Therapy for Neurological Disorders Forecast
10.1.5 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2 Americas Placental Stem Cell Therapy for Neurological Disorders Forecast by Country (2027-2032)
10.2.1 United States Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2.2 Canada Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2.3 Mexico Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2.4 Brazil Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3 APAC Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.3.1 China Placental Stem Cell Therapy for Neurological Disorders Market Forecast
10.3.2 Japan Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.3 Korea Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.4 Southeast Asia Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.5 India Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.6 Australia Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4 Europe Placental Stem Cell Therapy for Neurological Disorders Forecast by Country (2027-2032)
10.4.1 Germany Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.2 France Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.3 UK Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.4 Italy Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.5 Russia Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.5.1 Egypt Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5.2 South Africa Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5.3 Israel Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5.4 Turkey Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.6 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Type (2027-2032)
10.7 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Placental Stem Cell Therapy for Neurological Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 Mesoblast
11.1.1 Mesoblast Company Information
11.1.2 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Mesoblast Main Business Overview
11.1.5 Mesoblast Latest Developments
11.2 Pleurite Therapeutic
11.2.1 Pleurite Therapeutic Company Information
11.2.2 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pleurite Therapeutic Main Business Overview
11.2.5 Pleurite Therapeutic Latest Developments
11.3 Athersys
11.3.1 Athersys Company Information
11.3.2 Athersys Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Athersys Main Business Overview
11.3.5 Athersys Latest Developments
11.4 Cordlife India
11.4.1 Cordlife India Company Information
11.4.2 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cordlife India Main Business Overview
11.4.5 Cordlife India Latest Developments
11.5 Life Cell
11.5.1 Life Cell Company Information
11.5.2 Life Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Life Cell Main Business Overview
11.5.5 Life Cell Latest Developments
11.6 Cryo-Cell
11.6.1 Cryo-Cell Company Information
11.6.2 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cryo-Cell Main Business Overview
11.6.5 Cryo-Cell Latest Developments
11.7 CBR Systems
11.7.1 CBR Systems Company Information
11.7.2 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CBR Systems Main Business Overview
11.7.5 CBR Systems Latest Developments
11.8 ReNeuron Group
11.8.1 ReNeuron Group Company Information
11.8.2 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ReNeuron Group Main Business Overview
11.8.5 ReNeuron Group Latest Developments
11.9 Cynata
11.9.1 Cynata Company Information
11.9.2 Cynata Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cynata Main Business Overview
11.9.5 Cynata Latest Developments
11.10 Celularity
11.10.1 Celularity Company Information
11.10.2 Celularity Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Celularity Main Business Overview
11.10.5 Celularity Latest Developments
11.11 Americord Registry
11.11.1 Americord Registry Company Information
11.11.2 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Americord Registry Main Business Overview
11.11.5 Americord Registry Latest Developments
11.12 ReeLabs
11.12.1 ReeLabs Company Information
11.12.2 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ReeLabs Main Business Overview
11.12.5 ReeLabs Latest Developments
11.13 Mesoblast
11.13.1 Mesoblast Company Information
11.13.2 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Mesoblast Main Business Overview
11.13.5 Mesoblast Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size (2021-2032)
2.1.2 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Placental Stem Cell Therapy for Neurological Disorders by Country/Region (2021, 2025 & 2032)
2.2 Placental Stem Cell Therapy for Neurological Disorders Segment by Type
2.2.1 Allogeneic Placental Stem Cell Therapy
2.2.2 Autologous Placental Stem Cell Therapy
2.2.3 Placental Stem Cell Therapy for Neurological Disorders Market Size by Type
2.2.3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
2.3 Placental Stem Cell Therapy for Neurological Disorders Segment by Application
2.3.1 Hospitals and Specialist Clinics
2.3.2 Clinical Research Institute
2.3.3 Placental Stem Cell Therapy for Neurological Disorders Market Size by Application
2.3.3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
3 PLACENTAL STEM CELL THERAPY FOR NEUROLOGICAL DISORDERS MARKET SIZE BY PLAYER
3.1 Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Player
3.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2021-2026)
3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player (2021-2026)
3.2 Global Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PLACENTAL STEM CELL THERAPY FOR NEUROLOGICAL DISORDERS BY REGION
4.1 Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026)
4.2 Global Placental Stem Cell Therapy for Neurological Disorders Annual Revenue by Country/Region (2021-2026)
4.3 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
4.4 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
4.5 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
4.6 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026)
5.2 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
5.3 Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026)
6.2 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
6.3 APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026)
7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders by Region (2021-2026)
8.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026)
8.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PLACENTAL STEM CELL THERAPY FOR NEUROLOGICAL DISORDERS MARKET FORECAST
10.1 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.1.1 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.1.2 Americas Placental Stem Cell Therapy for Neurological Disorders Forecast
10.1.3 APAC Placental Stem Cell Therapy for Neurological Disorders Forecast
10.1.4 Europe Placental Stem Cell Therapy for Neurological Disorders Forecast
10.1.5 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2 Americas Placental Stem Cell Therapy for Neurological Disorders Forecast by Country (2027-2032)
10.2.1 United States Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2.2 Canada Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2.3 Mexico Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.2.4 Brazil Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3 APAC Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.3.1 China Placental Stem Cell Therapy for Neurological Disorders Market Forecast
10.3.2 Japan Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.3 Korea Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.4 Southeast Asia Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.5 India Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.3.6 Australia Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4 Europe Placental Stem Cell Therapy for Neurological Disorders Forecast by Country (2027-2032)
10.4.1 Germany Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.2 France Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.3 UK Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.4 Italy Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.4.5 Russia Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Forecast by Region (2027-2032)
10.5.1 Egypt Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5.2 South Africa Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5.3 Israel Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.5.4 Turkey Market Placental Stem Cell Therapy for Neurological Disorders Forecast
10.6 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Type (2027-2032)
10.7 Global Placental Stem Cell Therapy for Neurological Disorders Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Placental Stem Cell Therapy for Neurological Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 Mesoblast
11.1.1 Mesoblast Company Information
11.1.2 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Mesoblast Main Business Overview
11.1.5 Mesoblast Latest Developments
11.2 Pleurite Therapeutic
11.2.1 Pleurite Therapeutic Company Information
11.2.2 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pleurite Therapeutic Main Business Overview
11.2.5 Pleurite Therapeutic Latest Developments
11.3 Athersys
11.3.1 Athersys Company Information
11.3.2 Athersys Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Athersys Main Business Overview
11.3.5 Athersys Latest Developments
11.4 Cordlife India
11.4.1 Cordlife India Company Information
11.4.2 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cordlife India Main Business Overview
11.4.5 Cordlife India Latest Developments
11.5 Life Cell
11.5.1 Life Cell Company Information
11.5.2 Life Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Life Cell Main Business Overview
11.5.5 Life Cell Latest Developments
11.6 Cryo-Cell
11.6.1 Cryo-Cell Company Information
11.6.2 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cryo-Cell Main Business Overview
11.6.5 Cryo-Cell Latest Developments
11.7 CBR Systems
11.7.1 CBR Systems Company Information
11.7.2 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CBR Systems Main Business Overview
11.7.5 CBR Systems Latest Developments
11.8 ReNeuron Group
11.8.1 ReNeuron Group Company Information
11.8.2 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ReNeuron Group Main Business Overview
11.8.5 ReNeuron Group Latest Developments
11.9 Cynata
11.9.1 Cynata Company Information
11.9.2 Cynata Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cynata Main Business Overview
11.9.5 Cynata Latest Developments
11.10 Celularity
11.10.1 Celularity Company Information
11.10.2 Celularity Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Celularity Main Business Overview
11.10.5 Celularity Latest Developments
11.11 Americord Registry
11.11.1 Americord Registry Company Information
11.11.2 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Americord Registry Main Business Overview
11.11.5 Americord Registry Latest Developments
11.12 ReeLabs
11.12.1 ReeLabs Company Information
11.12.2 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ReeLabs Main Business Overview
11.12.5 ReeLabs Latest Developments
11.13 Mesoblast
11.13.1 Mesoblast Company Information
11.13.2 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Mesoblast Main Business Overview
11.13.5 Mesoblast Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Placental Stem Cell Therapy for Neurological Disorders Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Allogeneic Placental Stem Cell Therapy
Table 4. Major Players of Autologous Placental Stem Cell Therapy
Table 5. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 8. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 11. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player (2021-2026)
Table 13. Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Products Offered
Table 14. Placental Stem Cell Therapy for Neurological Disorders Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 19. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 23. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 25. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 27. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 29. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 33. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Placental Stem Cell Therapy for Neurological Disorders
Table 39. Key Market Challenges & Risks of Placental Stem Cell Therapy for Neurological Disorders
Table 40. Key Industry Trends of Placental Stem Cell Therapy for Neurological Disorders
Table 41. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Mesoblast Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 46. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 47. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Mesoblast Main Business
Table 49. Mesoblast Latest Developments
Table 50. Pleurite Therapeutic Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 51. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 52. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Pleurite Therapeutic Main Business
Table 54. Pleurite Therapeutic Latest Developments
Table 55. Athersys Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 56. Athersys Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 57. Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Athersys Main Business
Table 59. Athersys Latest Developments
Table 60. Cordlife India Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 61. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 62. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Cordlife India Main Business
Table 64. Cordlife India Latest Developments
Table 65. Life Cell Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 66. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 67. Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Life Cell Main Business
Table 69. Life Cell Latest Developments
Table 70. Cryo-Cell Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 71. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 72. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Cryo-Cell Main Business
Table 74. Cryo-Cell Latest Developments
Table 75. CBR Systems Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 76. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 77. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. CBR Systems Main Business
Table 79. CBR Systems Latest Developments
Table 80. ReNeuron Group Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 81. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 82. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. ReNeuron Group Main Business
Table 84. ReNeuron Group Latest Developments
Table 85. Cynata Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 86. Cynata Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 87. Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Cynata Main Business
Table 89. Cynata Latest Developments
Table 90. Celularity Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 91. Celularity Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 92. Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Celularity Main Business
Table 94. Celularity Latest Developments
Table 95. Americord Registry Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 96. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 97. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Americord Registry Main Business
Table 99. Americord Registry Latest Developments
Table 100. ReeLabs Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 101. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 102. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. ReeLabs Main Business
Table 104. ReeLabs Latest Developments
Table 105. Mesoblast Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 106. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 107. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Mesoblast Main Business
Table 109. Mesoblast Latest Developments
Table 1. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Placental Stem Cell Therapy for Neurological Disorders Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Allogeneic Placental Stem Cell Therapy
Table 4. Major Players of Autologous Placental Stem Cell Therapy
Table 5. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 8. Placental Stem Cell Therapy for Neurological Disorders Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 11. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player (2021-2026)
Table 13. Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Products Offered
Table 14. Placental Stem Cell Therapy for Neurological Disorders Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 19. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 23. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Table 25. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Table 27. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Table 29. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country (2021-2026)
Table 33. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Placental Stem Cell Therapy for Neurological Disorders
Table 39. Key Market Challenges & Risks of Placental Stem Cell Therapy for Neurological Disorders
Table 40. Key Industry Trends of Placental Stem Cell Therapy for Neurological Disorders
Table 41. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Mesoblast Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 46. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 47. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Mesoblast Main Business
Table 49. Mesoblast Latest Developments
Table 50. Pleurite Therapeutic Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 51. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 52. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Pleurite Therapeutic Main Business
Table 54. Pleurite Therapeutic Latest Developments
Table 55. Athersys Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 56. Athersys Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 57. Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Athersys Main Business
Table 59. Athersys Latest Developments
Table 60. Cordlife India Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 61. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 62. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Cordlife India Main Business
Table 64. Cordlife India Latest Developments
Table 65. Life Cell Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 66. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 67. Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Life Cell Main Business
Table 69. Life Cell Latest Developments
Table 70. Cryo-Cell Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 71. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 72. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Cryo-Cell Main Business
Table 74. Cryo-Cell Latest Developments
Table 75. CBR Systems Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 76. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 77. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. CBR Systems Main Business
Table 79. CBR Systems Latest Developments
Table 80. ReNeuron Group Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 81. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 82. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. ReNeuron Group Main Business
Table 84. ReNeuron Group Latest Developments
Table 85. Cynata Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 86. Cynata Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 87. Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Cynata Main Business
Table 89. Cynata Latest Developments
Table 90. Celularity Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 91. Celularity Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 92. Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Celularity Main Business
Table 94. Celularity Latest Developments
Table 95. Americord Registry Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 96. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 97. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Americord Registry Main Business
Table 99. Americord Registry Latest Developments
Table 100. ReeLabs Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 101. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 102. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. ReeLabs Main Business
Table 104. ReeLabs Latest Developments
Table 105. Mesoblast Details, Company Type, Placental Stem Cell Therapy for Neurological Disorders Area Served and Its Competitors
Table 106. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product Offered
Table 107. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Mesoblast Main Business
Table 109. Mesoblast Latest Developments
LIST OF FIGURES
Figure 1. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Placental Stem Cell Therapy for Neurological Disorders Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Placental Stem Cell Therapy for Neurological Disorders Sales Market Share by Country/Region (2025)
Figure 8. Placental Stem Cell Therapy for Neurological Disorders Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type in 2025
Figure 10. Placental Stem Cell Therapy for Neurological Disorders in Hospitals and Specialist Clinics
Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market: Hospitals and Specialist Clinics (2021-2026) & ($ millions)
Figure 12. Placental Stem Cell Therapy for Neurological Disorders in Clinical Research Institute
Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market: Clinical Research Institute (2021-2026) & ($ millions)
Figure 14. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application in 2025
Figure 15. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player in 2025
Figure 16. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 17. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 18. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 19. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 21. Americas Placental Stem Cell Therapy for Neurological Disorders Value Market Share by Country in 2025
Figure 22. United States Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region in 2025
Figure 27. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 28. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 29. China Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 33. India Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country in 2025
Figure 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 37. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 38. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 39. France Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 52. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 53. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 55. United States Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 56. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 57. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 58. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 59. China Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 60. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 61. Korea Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 63. India Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 64. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 65. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 66. France Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 67. UK Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 68. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 69. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 70. Egypt Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 71. South Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 72. Israel Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 73. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 74. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 1. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Placental Stem Cell Therapy for Neurological Disorders Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Placental Stem Cell Therapy for Neurological Disorders Sales Market Share by Country/Region (2025)
Figure 8. Placental Stem Cell Therapy for Neurological Disorders Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type in 2025
Figure 10. Placental Stem Cell Therapy for Neurological Disorders in Hospitals and Specialist Clinics
Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market: Hospitals and Specialist Clinics (2021-2026) & ($ millions)
Figure 12. Placental Stem Cell Therapy for Neurological Disorders in Clinical Research Institute
Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market: Clinical Research Institute (2021-2026) & ($ millions)
Figure 14. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application in 2025
Figure 15. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Player in 2025
Figure 16. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 17. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 18. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 19. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2021-2026 ($ millions)
Figure 21. Americas Placental Stem Cell Therapy for Neurological Disorders Value Market Share by Country in 2025
Figure 22. United States Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region in 2025
Figure 27. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 28. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 29. China Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 33. India Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Country in 2025
Figure 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 37. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 38. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 39. France Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Placental Stem Cell Therapy for Neurological Disorders Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 52. APAC Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 53. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 55. United States Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 56. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 57. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 58. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 59. China Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 60. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 61. Korea Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 63. India Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 64. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 65. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 66. France Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 67. UK Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 68. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 69. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 70. Egypt Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 71. South Africa Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 72. Israel Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 73. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
Figure 74. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Placental Stem Cell Therapy for Neurological Disorders Market Size 2027-2032 ($ millions)
